179 related articles for article (PubMed ID: 29070518)
21. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
[TBL] [Abstract][Full Text] [Related]
23. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.
Yu L; Shang ZF; Hsu FM; Zhang Z; Tumati V; Lin YF; Chen BP; Saha D
Oncotarget; 2015 Feb; 6(6):3848-60. PubMed ID: 25714019
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP.
Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W
Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581
[TBL] [Abstract][Full Text] [Related]
25. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.
Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B
Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980
[TBL] [Abstract][Full Text] [Related]
26. c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer.
Jung J; Kim EJ; Chung HK; Park HJ; Jeong SY; Choi EK
Int J Oncol; 2012 Feb; 40(2):385-90. PubMed ID: 21947247
[TBL] [Abstract][Full Text] [Related]
27. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo.
Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B
Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409
[TBL] [Abstract][Full Text] [Related]
28. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
29. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.
Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M
Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064
[TBL] [Abstract][Full Text] [Related]
30. Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression.
Sanli T; Liu C; Rashid A; Hopmans SN; Tsiani E; Schultz C; Farrell T; Singh G; Wright J; Tsakiridis T
J Thorac Oncol; 2011 Mar; 6(3):439-50. PubMed ID: 21258249
[TBL] [Abstract][Full Text] [Related]
31. Role of the microenvironment for radiosensitization by patupilone.
Bley CR; Jochum W; Orlowski K; Furmanova P; Vuong V; McSheehy PM; Pruschy M
Clin Cancer Res; 2009 Feb; 15(4):1335-42. PubMed ID: 19228735
[TBL] [Abstract][Full Text] [Related]
32. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
Wang L; Long L; Wang W; Liang Z
J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
[TBL] [Abstract][Full Text] [Related]
34. Luteolin acts as a radiosensitizer in non‑small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade.
Cho HJ; Ahn KC; Choi JY; Hwang SG; Kim WJ; Um HD; Park JK
Int J Oncol; 2015 Mar; 46(3):1149-58. PubMed ID: 25586525
[TBL] [Abstract][Full Text] [Related]
35. Microcystin-LR induces a wide variety of biochemical changes in the A549 human non-small cell lung cancer cell line: Roles for protein phosphatase 2A and its substrates.
Wang H; Xu K; Wang B; Liu J; Wang X; Xing M; Huang P; Guo Z; Xu L
Environ Toxicol; 2017 Mar; 32(3):1065-1078. PubMed ID: 27352821
[TBL] [Abstract][Full Text] [Related]
36. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
37. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe.
Oike T; Komachi M; Ogiwara H; Amornwichet N; Saitoh Y; Torikai K; Kubo N; Nakano T; Kohno T
Radiother Oncol; 2014 May; 111(2):222-7. PubMed ID: 24746574
[TBL] [Abstract][Full Text] [Related]
38. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
Kim W; Youn H; Kang C; Youn B
Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitizing Effect of Novel Phenylpyrimidine Derivatives on Human Lung Cancer Cells via Cell Cycle Perturbation.
Jung SY; Nam KY; Park JI; Song KH; Ahn J; Park JK; Um HD; Hwang SG; Choi SU; Song JY
J Pharmacol Exp Ther; 2019 Sep; 370(3):514-527. PubMed ID: 31253693
[TBL] [Abstract][Full Text] [Related]
40. Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts.
Chargari C; Leteur C; Angevin E; Bashir T; Schoentjes B; Arts J; Janicot M; Bourhis J; Deutsch E
Cancer Lett; 2011 Dec; 312(2):209-18. PubMed ID: 21937165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
